| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
Saturday, November 9 | 8 a.m. to 5 p.m.
The Spectrum of Precision Medicine
Session I: Precision Medicine in 2019, 8:05–8:25 a.m.
Konstantinos Lazaridis, M.D.
AFLD: Risk Stratification and Managing Co-Morbidities
Session II: Evolution of Disease and Reversing Fibrosis, 9:45–10:05 a.m.
Kymberly Watt, M.D.
Managing HCV Cirrhotic Patients after Achieving SVR: Who Will Progress to Developing HepatocellularCarcinoma?
Session IV: Hepatic Neoplasms, 1:30–1:50 p.m.
Tushar Patel, M.B., Ch.B.
Saturday, November 9 | 12–1:30 p.m.
These highly interactive, small group sessions are opportunities for attendees to engage with well-known liver disease experts. Researchers and clinicians can ask questions, explore a wide variety of timely topics, and network with peers and leaders in the field.
Ask the Expert on Hepatitis C: HCV—Special Population
Location: MTP 04
Donald Jensen, M.D., and Hugo Vargas, M.D.
Emerging Treatments in Alcoholic Liver Disease
Location: MTP 08
Vijay Shah, M.D., and Ashwani Singal, M.D.
Using Hepatitis C Positive and PHS Increased Risk Organs: Practice and Pitfalls
Location: MTP 10
Michael Curry, M.D., and Surakit Pungpapong, M.D.
When to Pursue Bariatric Surgery in Patients with Advanced NASH
Location: MTP 14
Julie Heimbach, M.D., and Naga Chalasani, M.D.
Saturday, November 9–Monday, November 11
Kick-start your day at The Liver Meeting® with these highly interactive sessions focusing on specialized areas of liver disease or investigation. Early birds will enjoy both the stimulating discussions of new science and the opportunity to network with experts and peers in a small group setting.
Basic Workshop:
Molecular Pathogenesis of Intrahepatic Cholangiocarcinoma
Saturday, November 9 | 6:45–7:45 a.m.
Gregory Gores, M.D., and Alphonse Sirica, Ph.D.
Location: EMW 01
Clinical Workshop:
Taking the Patient with Cirrhosis to Surgery: An Evidence-Based Risk Assessment
Sunday, November 10 | 6:45–7:45 a.m.
Julie Heimbach, M.D., and Lawrence Friedman, M.D.
Location: EMW 29
Basic Workshop:
Engineering of Biliary Organoids
Monday, November 11 | 6:45–7:45 a.m.
Robert Huebert, M.D., and Carol Soroka, Ph.D.
Location: EMW 35
Clinical Workshop:
New Drugs and End-Points for NASH
Monday, November 11 | 6:45–7:45 a.m.
Rohit Loomba, M.D., and Alina Allen, M.D.
Location: EMW 40
Clinical Workshop:
Fontan Hepatopathy: Monitoring Progression of Liver Disease
Monday, November 11 | 6:45–7:45 a.m.
Douglas Simonetto, M.D., and Daniel Ganger, M.D.
Location: EMW 45
Liver Transplantation and Surgery SIG and Pediatric Liver Disorders
Optimizing Allograft Health Over a Lifetime
Monday, November 11 | 2–6 p.m.
Program Chairs, Veena Venkat, M.D., and Timucin Taner, M.D., Ph.D.
Discover how allocation impacts long-term outcomes for the transplant recipient and liver graft at this session. Speakers will address ways to improve the ability to interpret and identify the significance of long-term, post-transplant liver biopsy findings and offer tools to expand one’s perspective on individualizing immunosuppression to optimize long-term outcomes for the allograft and recipient.
